Exeltis Magyarország

What Exeltis Magyarország does

Exeltis Magyarország Kft. is a Budapest-headquartered private limited company (Kft.) incorporated in Hungary in 2003 and operating as the Hungarian subsidiary of the global Exeltis pharmaceutical group. The entity is a sales, marketing, and distribution arm focused on four therapeutic verticals: women's health (primary), endocrinology, andrology, and urology. Its product portfolio comprises both prescription pharmaceuticals and over-the-counter/medical-device items distributed through branded franchises including Inofolic (myo-inositol, folic acid, selenium fertility support), Velfem and Ladeevit (prenatal vitamins), Deflagyn and Lactofeel (vaginal infection treatments), Santes (menopause management), Delphys (myoma symptom relief), Folandrol (male fertility), and Normoxil (fertility support), distributed via dedicated Hungarian-language product websites.

The underlying technology is generic pharmaceutical formulation rather than proprietary platforms; products address contraception, fertility, pregnancy preparation, vaginal infections, menopause, urinary tract infections, thyroid disorders, and benign prostatic hyperplasia. Distribution is professional-to-professional: products move through pharmacy channels and are prescribed or recommended by gynecologists, urologists, endocrinologists, and general practitioners. The company engages healthcare professionals through training programs (with disclosed training/consultancy payments of 2,650,000 HUF in 2024 and 3,520,000 HUF in 2025), conference sponsorships across major Hungarian specialty congresses, and foundation support disbursements to at least eight healthcare organizations in 2024 totaling roughly 8.15 million HUF.

Revenue is generated through one-time sales of prescription and OTC pharmaceutical products under Hungary's reimbursement and pricing framework; no revenue figures are publicly disclosed. The company operates under the EFPIA Transparency Code and Hungary's Generic Transparency Code as a member of the Hungarian Generic Pharmaceutical Manufacturers and Distributors Association, and uses the Medicines for Europe disclosure template, making its HCP and healthcare organization payments public. With 11-50 employees and a single-country footprint, Exeltis Magyarország functions as a focused commercial affiliate within the larger 44+ country Exeltis group that markets 300+ products and engages 4,000+ healthcare professionals globally.

Name

Exeltis Magyarország

Legal name

Exeltis Magyarország Kft.

Website

https://exeltis.hu

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Exeltis Magyarország Kft. is a Budapest-based generic pharmaceutical subsidiary distributing women's health, endocrinology, andrology, and urology products through Hungarian pharmacies and healthcare professional networks under the global Exeltis brand.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIAAAJ

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIABAL

Generic Hospital & Institutional Products

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Generic pharmaceuticals
• Women's health products
• Fertility supplements
• Endocrinology therapeutics
• Urology medications

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Supply Chain, Operations, Others

Revenue model

1. Prescription Pharmaceutical Products: Exeltis Magyarország generates revenue through the sale of generic pharmaceutical products across therapeutic areas including women's health, endocrinology, andrology, and urology. Products include prescription medications for contraception, fertility, pregnancy, vaginal infections, menopause, urinary tract infections, thyroid disorders, and benign prostatic hyperplasia. Revenue is generated through pharmacy distribution and healthcare professional prescriptions.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Exeltis Magyarország is the Hungarian affiliate of the international Exeltis pharmaceutical group. It markets and distributes a portfolio of branded generic pharmaceuticals primarily in women's health, fertility, endocrinology, andrology, and urology to healthcare professionals and pharmacies across Hungary.

Product overview

Exeltis Magyarország is a pharmaceutical company offering a portfolio of prescription and over-the-counter products focused on four therapeutic areas: Women's Health (fogamzásgátlás/contraception, fertilitás/fertility, várandósság/pregnancy, hüvelyfertőzések/vaginal infections, menopauza/menopause, húgyúti fertőzések/urinary infections), Endocrinology (pajzsmirigy/thyroid, fertilitás/fertility), Andrology (fertilitás/fertility), and Urology (húgyúti fertőzések/urinary infections, jóindulatú prosztata megnagyobbodás/benign prostatic hyperplasia). The product portfolio includes branded nutritional supplements such as Inofolic (Combi Premium, Premium), Normoxil, Velfem, Ladeevit, Folandrol; medical devices including Deflagyn, Lactofeel, Santes, and Delphys. Products are primarily distributed through healthcare professional login-registered accounts on exeltis.hu.

Differentiator

Problem solved

Functional benefit

Brands

• Inofolic: Mio-inozitol, folsav és szelén tartalmú készítmény nőknek a gyermekáldásra való felkészüléshez
• Inofolic Premium
• Inofolic Combi Premium
• Normoxil
• Velfem
• Ladeevit
• Deflagyn
• Lactofeel
• Santes
• Delphys
• Folandrol

Products and services

• Inofolic
• Inofolic Premium
• Inofolic Combi Premium
• Normoxil
• Velfem

Quantifiable outcome

• 300+ pharmaceutical products across therapeutic areas
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• Generikus Gyógyszergyártók és Forgalmazók Magyarországi Érdekvédelmi Egyesülete (Hungarian Generic Pharmaceutical Manufacturers and Distributors Association)coreOthersExeltis Magyarország Kft. is a member of the Hungarian Generic Pharmaceutical Manufacturers and Distributors Association. As a member, the company is bound by the Generic Transparency Code for Disclosure of Benefits Provided to Healthcare Professionals and Healthcare Organizations, as well as the Pharmaceutical Communication Ethics Code.
• EFPIA (European Federation of Pharmaceutical Industries and Associations)coreOthersExeltis operates under the EFPIA Transparency Code framework adopted in June 2013, which governs disclosure of benefits provided to healthcare professionals and organizations. The transparency code ensures ethical collaboration between the pharmaceutical industry and healthcare workers for better disease understanding, drug development, and patient treatment outcomes.
• Medicines for EuropeminorOthersExeltis uses the Medicines for Europe Code of Conduct template for transparency reporting, ensuring standardized disclosure of payments to healthcare professionals and organizations.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Sandoz:
• Insud Pharma: Spanish parent group of the global Exeltis network. Parent rather than competitor; included for context on corporate ownership and capital allocation drivers.

Direct peers

• Theramex: Women's health specialty pharma covering contraception, fertility, and menopause across Europe. Direct competitor in the same therapeutic categories, especially in CEE and EU markets.
• Organon: Global women's health-focused pharmaceutical company spun off from Merck, covering contraception, fertility, and menopause. Closely aligned specialty focus to Exeltis's core therapeutic area.
• Gedeon Richter: Hungarian-headquartered pharmaceutical company with a strong women's health and generic portfolio. Most directly comparable domestic competitor operating in the same therapeutic categories and Hungarian market.
• EGIS Pharmaceuticals: Hungarian generic and specialty pharmaceutical manufacturer (part of Servier group) with overlapping therapeutic categories including women's health and endocrinology. Direct in-market competitor.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with broad women's health offerings. Competes in Hungary across generics and biosimilars with much larger scale and broader portfolio.
• Viatris: Global generics and specialty pharma with significant presence in women's health and CEE region. Broad-based competitor across generic portfolio.
• Bayer (Pharmaceuticals): Large incumbent with established women's health franchise (contraception, menopause, gynecological therapies). Overlaps in key therapeutic categories with significantly larger commercial scale.
• Stada Arzneimittel: European generics and consumer healthcare group with Central European footprint. Competes in similar generic and OTC categories in CEE markets including Hungary.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exeltis Magyarország